The Hatter Cardiovascular Institute, UCL – webinar series for trainees – cardiology, diabetes, nephrology
1. Emerging therapies affecting cardiovascular, renal and metabolic medicine
Prof Mansoor Husain, University of Toronto, Toronto, Canada
2. SpR case presentations: Out of my comfort zone!
i). Cardiovascular – Dr Ali Rauf, Cardiology SpR
How do I handle a patient with renal/diabetic co-morbidities?
ii). Renal – Dr Tamek Rezek, Nephrology SpR
How do I handle a patient with cardiac/diabetic co-morbidities?
iii). Metabolic – Dr Eleni Armeni, Diabetes and Endocrinology SpR
How do I handle a patient with cardiac/renal co-morbidities
3. Breakout Discussion by Trainees
Arrhythmia Alliance Heart Rhythm Congress 2021 (A-A HRC 2021) — all at a touch of a button, available on-demand at a time to suit you no matter where you are in the world — is for all those interested in expanding their knowledge of cardiac arrhythmias and is worth up to 24 CPD points.
A-A HRC 2021 launches 3rd October 2021 with 200 plus hours of first-class education, combining both LIVE and on-demand content. There will be expert speakers from across the globe — including: Profs John Camm, Hugh Calkins, Christine Albert, Sabine Ernst, Kenneth Ellenbogen, Blair Grubb, Robert Sheldon, Richard Sutton and many more...
The congress will explore the latest research, innovative technologies, and the newest guidelines. Furthermore, it will review the impact that COVID-19 has had on arrhythmia services — asking what lessons have been learnt and how these will affect delivery of services in the future.
A-A HRC2021 is dedicated to healthcare professionals across all disciplines with an interest in arrhythmias. There is something for everyone from consultant electrophysiologists, fellows, trainees, clinical scientists, general cardiologists, nurses, physiologists to general practitioners, stroke physicians and policy makers. Whatever your role in the healthcare team, there will be sessions at HRC2021 that meet your needs and improves your education.
There will be sessions from:
Not able to attend on 3rd October? Do not worry! All content will be available on our bespoke virtual platform until end of September 2022 – 12 months access and regularly updated.
* Registration fee (HCP/Industry) = £50 (US$ or currency of your choice) payable via PayPal, Credit or Debit card.
For enquiries, please e-mail firstname.lastname@example.org
Friday 8th October 2021 10.30 – 15.10 BST
We hope healthcare professionals will join us virtually for our popular annual scientific meeting, which will be broadcast live this year and free to attend. The meeting will focus on improving the care we deliver to patients with a broad spectrum of cardiorenal disease, incorporating an evidence-based approach.
Targets, treatments and new data with a particular focus on heart failure, diabetes, chronic kidney disease (CKD) and lipid management will be discussed by speakers from centres around the UK. Practical workshops on the presentations will be an integral part of this year’s programme. These will feature cases and discussion of service delivery.
The day will be hosted by a multidisciplinary faculty in the studio, who will pose your questions to the experts, lead the discussion and contribute to the workshops.
This independent meeting will be supported and funded by a number of pharmaceutical companies.
This meeting is for healthcare professionals. It is aimed at anyone treating the cardiorenal patient particularly those working in heart failure, cardiology, nephrology, diabetes, lipids, endocrinology, care of the elderly, general medicine, general practice, clinical pharmacy and allied disciplines.
4 CPD/CME credits
The Cardiorenal Forum has assigned 4 hours of CPD/CME credit to this meeting. Certificates of attendance will be sent after the meeting.
The Cardiorenal Forum Annual Scientific Meeting is supported by KDIGO (Kidney Disease Improving Global Outcomes)
Scottish Heart and Arterial Risk disease Prevention (SHARP), Scotland's national cardiovascular research organisation, is back with a stellar meeting on Thursday 28th November 2021. Their Annual Scientific Meeting, together with the Scottish Lipid Forum, has a host of stars:
Keen to register and/or submit an abstract? Log on to:
Registration is free, likewise abstract submission.
The meeting is hybrid: both streamed - and as a return towards normal - with limited places available to on site delegates at the Royal College of Physicians of Edinburgh, where the event is being hosted.
Register your interest now!
For further details, contact SHARP at:
Or contact us directly at Glasgow Royal Infirmary. Look forward to seeing you there!
Start: Wednesday 1st Dec 2021 - End: Friday 3rd Dec 2021
‘We are delighted to invite you to register for ‘Freedom from Failure’, the British Society for Heart Failure’s Hybrid Annual Meeting 2021.
As always, we have an impactful, informational and engaging educational programme, complemented with an interactive virtual exhibition.
The programme design is optimised for both in person and virtual attendance. With a renowned faculty, choice of sessions and opportunities for networking over 2.5 days from 1st – 3rd December 2021, we will be welcoming a global audience.
There will be a limited number of physical places available in the QEII London to maintain a degree of social distancing to protect delegates.
Those who live in the UK outside of the M25 who wish to take up a physical place at the annual meeting will have the option of applying for a travel grant, details of criteria and how to apply are available on the BSH website.
Scientific Chairs Christoph Binder (Medical University of Vienna), Ziad Mallat (University of Cambridge) & Eicke Latz (University of Bonn) are coming together once again to host the 3rd Immuno-Metabolic Mechanisms of Atherosclerosis Conference. The meeting will be taking place in person from 01-04 May 2022 at the Fiesta Americana Tulkal Riviera Maya, Mexico.
Building on the success of the previous meetings, the main goal of this meeting is to provide attendees with a comprehensive overview of current research on atherosclerosis with a focus on the latest and most exciting developments in the immuno-metabolic mechanisms that govern disease initiation and progression. There is little doubt that the next most exciting therapy to combat cardiovascular disease will be based on targeting biological pathways that will have been discussed during this conference.
Seven sessions are planned and will highlight the following major research areas:
Find out more and register your interest here: https://www.fusion-conferences.com/conference/131
The deadlines for submitting a talk or a poster are as follows: